ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Use of Autotransfusion During Liver Transplantation for Hepatocellular Carcinoma Does Not Increase Recurrence.

A. Gupta, M. Ramsay, G. Saracino, T. Anthony, R. Goldstein, G. McKenna, N. Onaca, R. Ruiz, G. Klintmalm, P. Kim.

Baylor University Medical Center, Dallas, TX.

Meeting: 2016 American Transplant Congress

Abstract number: A185

Keywords: Blood transfusion, Hepatocellular carcinoma, Liver transplantation, Recurrence

Session Information

Session Name: Poster Session A: Liver - Hepatocellular Carcinoma and Cholangiocarcinoma Malignancies

Session Type: Poster Session

Date: Saturday, June 11, 2016

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Halls C&D

Introduction

Autotransfusion (AT) is rarely used in liver transplantation of hepatocellular carcinoma (HCC) patients due to the fear of disease transmission. Leukocyte depleting filters (LDF) can remove HCC cells from blood. We aim to evaluate the safety of AT with LDF during transplantation in HCC patients.

Methods

A retrospective study of a prospectively obtained database of HCC patients transplanted from 12/2012 – 08/2015, was stratified into 2 groups: an AT Cohort and a Control Group. Surveillance of recurrence was performed using protocol chest CT and abdominal MRI. The groups were compared for HCC recurrence, patient and disease-free survival.

Results

94 HCC patients were included: AT Cohort (n=43) and Control Group (n=51). No differences in recipient and donor demographics were seen except a longer WIT in the AT Group (55min vs 45min, p=0.04). There was no difference in tumor criteria including tumor grade, vascular invasion, pretransplant chemoembolization or patients within Milan and Region 4 criteria. There was similar PRBC use between the AT Cohort and Control Group (5.6 vs 3.6U, p=0.72). There were no recurrences of HCC in the in the AT Cohort and 1 recurrence in the Control Group (p=1.00) (figure 1). The 1-year survival in the AT Cohort vs Control Group was 95% vs 92% (p=0.75) (figure 2).

Conclusions

This study demonstrates the use of AT with LDF in HCC patients with no increase in HCC recurrence after short-term follow up. The authors advocate the use of AT with LDF in liver transplantation for HCC.

CITATION INFORMATION: Gupta A, Ramsay M, Saracino G, Anthony T, Goldstein R, McKenna G, Onaca N, Ruiz R, Klintmalm G, Kim P. Use of Autotransfusion During Liver Transplantation for Hepatocellular Carcinoma Does Not Increase Recurrence. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Gupta A, Ramsay M, Saracino G, Anthony T, Goldstein R, McKenna G, Onaca N, Ruiz R, Klintmalm G, Kim P. Use of Autotransfusion During Liver Transplantation for Hepatocellular Carcinoma Does Not Increase Recurrence. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/use-of-autotransfusion-during-liver-transplantation-for-hepatocellular-carcinoma-does-not-increase-recurrence/. Accessed May 8, 2025.

« Back to 2016 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences